European Communities – measures affecting the approval
and marketing of biotech products

STATUS REPORT BY THE EUROPEAN UNION

Addendum

The following communication, dated 13 April 2022, from the delegation of the European Union to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

_______________

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document WT/DS293/41) and Canada (WT/DS292/40), the European Union remains ready to continue its discussions with the United States with the goal of resolving this dispute and related issues.

__________